These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 5065462)

  • 1. The occurrence of human insulin-binding antibodies in diabetes.
    Kosowicz J; Czekalski S; Fajfrowski T
    Pol Med J; 1972; 11(3):495-501. PubMed ID: 5065462
    [No Abstract]   [Full Text] [Related]  

  • 2. Some characteristics of insulin antibodies in nonresistant diabetes.
    Lev-Ran A; Ratt L; Laor J
    Isr J Med Sci; 1972 Jun; 8(6):905-6. PubMed ID: 5065914
    [No Abstract]   [Full Text] [Related]  

  • 3. [Use of labeled insulin for a study of insulin antibodies. II. Study of antibodies in a patient with resistance to insulin].
    Foit R; Sieberová R; Kraml J; Prokes J; Zikmund E
    Vnitr Lek; 1968 Jun; 14(6):530-8. PubMed ID: 5661807
    [No Abstract]   [Full Text] [Related]  

  • 4. [The use of human insulin in 3 patients with diabetes mellitus and insulin resistance].
    Khristov V; Manov A
    Vutr Boles; 1989; 28(1):51-6. PubMed ID: 2662609
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunogenicity of bovine, porcine and semisynthetic human insulin.
    Venekamp WJ; van der Hooft JC; Jacobsen L; van Schaik CL
    Neth J Med; 1985; 28 Suppl 1():57-8. PubMed ID: 3892343
    [No Abstract]   [Full Text] [Related]  

  • 6. The immunogenic properties of a highly purified insulin preparation.
    Manning NT; Drury MI
    Ir J Med Sci; 1979 Apr; 148(4):135-9. PubMed ID: 393651
    [No Abstract]   [Full Text] [Related]  

  • 7. [Effect on insulin antibodies on the effect iveness of insulin in metabolism].
    Bemm VH; Lohmann D; Thomitzek W-D ; Verlohren H-D
    Dtsch Z Verdau Stoffwechselkr; 1971; 31(2):91-6. PubMed ID: 5173538
    [No Abstract]   [Full Text] [Related]  

  • 8. [The study of insulin antibodies in different forms of diabetes mellitus].
    Mincu I; Ionescu-Tirgovişte C; Cheţa D; Simionescu L; Mirodon Z; Vasilescu V; Bruckner I
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1979; 31(5):421-8. PubMed ID: 44565
    [No Abstract]   [Full Text] [Related]  

  • 9. [Antibodies to insulin in patients with diabetes mellitus].
    Kozopolianskaia MM; Poltorak VV; Stetsenko KP
    Vrach Delo; 1973 Feb; 2():110-2. PubMed ID: 4722307
    [No Abstract]   [Full Text] [Related]  

  • 10. Immunologic sensitization of circulating basophils to exogenous insulin in diabetic patients.
    Emanuelli G; Gatti G; Calcamuggi G; Anfossi G; Cotto A; Marcarino C; Camussi G; Ottone G
    Panminerva Med; 1981; 23(2):81-8. PubMed ID: 7033894
    [No Abstract]   [Full Text] [Related]  

  • 11. Insulin antibody formation. I. The influence of age, sex, infections, insulin dosage and regulation of diabetes.
    Andersen OO
    Acta Endocrinol (Copenh); 1972 Sep; 71(1):126-40. PubMed ID: 4678008
    [No Abstract]   [Full Text] [Related]  

  • 12. Monocomponent insulin in maturity onset diabetes mellitus.
    Viswanathan M; Ramachandran A; Snehalatha C; Viswanathan M
    J Indian Med Assoc; 1981 Mar; 76(5):73-5. PubMed ID: 7021694
    [No Abstract]   [Full Text] [Related]  

  • 13. Evaluation of insulin antibodies in insulin treated patients.
    Giampietro O; Giannessi D; Del Chicca MG; Luche AD; Zucchelli GC; Navalesi R
    J Nucl Med Allied Sci; 1980; 24(3-4):153-8. PubMed ID: 7019394
    [No Abstract]   [Full Text] [Related]  

  • 14. Insulin antibodies and the control of diabetes.
    Dixon K; Exon PD; Malins JM
    Q J Med; 1975 Oct; 44(176):543-53. PubMed ID: 1105646
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The prevalence of proinsulin-specific antibodies in diabetic patients.
    Kumar D; Miller LV
    Horm Metab Res; 1973 Jan; 5(1):1-3. PubMed ID: 4735948
    [No Abstract]   [Full Text] [Related]  

  • 16. [Intravenous insulin treatment of chronic insulin resistance].
    Lohmann D; Janusch H; Bemm H; Rotzsch W; Kluge HO
    Dtsch Z Verdau Stoffwechselkr; 1968; 28(5):337-44. PubMed ID: 5731588
    [No Abstract]   [Full Text] [Related]  

  • 17. Insulin-binding antibody and hormone dosage in non-resistant diabetes.
    Hurn BA; Farrant PC; Young BA; Grahame A
    Postgrad Med J; 1969 Dec; ():Suppl:819+. PubMed ID: 5393006
    [No Abstract]   [Full Text] [Related]  

  • 18. [Modern aspects of pathogenesis in diabetes mellitus].
    Spanár E; Zahradny V; Uhrín P; Levcik A
    Z Gesamte Inn Med; 1974 Jun; 29(11):433-8. PubMed ID: 4849195
    [No Abstract]   [Full Text] [Related]  

  • 19. [Diabetes mellitus. Its treatment with monocompound purified insulin].
    Mirouze J; Orsetti A; Schmouker Y; Cartry E; Almes N
    Nouv Presse Med; 1973 Sep; 2(30):1981-5. PubMed ID: 4738370
    [No Abstract]   [Full Text] [Related]  

  • 20. [Insulin therapy and the nature of immunologic reactions to insulin and pancreatic tissue in diabetes mellitus].
    Afanas'eva SN
    Ter Arkh; 1982; 54(10):30-2. PubMed ID: 6758171
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.